Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study has been completed.
Study NCT00001287 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Demyelinating Diseases
Paraproteinemias
Additional conditions recognized in this trial
Polyneuropathies
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Blood Protein Disorders
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Polyradiculoneuropathy
Interventions listed in this trial
intravenous immunoglobulin (IVIg)
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)
Back to top of Main Content
